v3.25.2
SCHEDULE OF RESTATEMENTS OF OPERATIONS (Details) - USD ($)
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
New Accounting Pronouncements or Change in Accounting Principle [Line Items]    
Research and Development $ 363,350 $ 797,112
Loss from Investment in Iveda Phils JV (180,000)
Net Loss $ (3,980,820) $ (4,142,666)
Earnings Per Share, Basic $ (1.81) $ (2.07)
Earnings Per Share, Diluted $ (1.81) $ (2.07)
Previously Reported [Member]    
New Accounting Pronouncements or Change in Accounting Principle [Line Items]    
Research and Development   $ 4,500
Loss from Investment in Iveda Phils JV  
Eliminate JV G&A recorded 2023   162,686
Eliminate JV Interest Income recorded 2023   (11)
Eliminate Loss attributable to non-controlled interest   (97,605)
Net Loss   $ (3,235,124)
Earnings Per Share, Basic   $ 0.20
Earnings Per Share, Diluted   $ 0.20
Revision of Prior Period, Reclassification, Adjustment [Member]    
New Accounting Pronouncements or Change in Accounting Principle [Line Items]    
Research and Development   $ 792,612
Loss from Investment in Iveda Phils JV   180,000
Eliminate JV G&A recorded 2023   (162,686)
Eliminate JV Interest Income recorded 2023   11
Eliminate Loss attributable to non-controlled interest   97,605
Net Loss   (907,542)
Restated [Member]    
New Accounting Pronouncements or Change in Accounting Principle [Line Items]    
Research and Development   797,112
Loss from Investment in Iveda Phils JV   180,000
Eliminate JV G&A recorded 2023  
Eliminate JV Interest Income recorded 2023  
Eliminate Loss attributable to non-controlled interest  
Net Loss   $ (4,142,666)
Earnings Per Share, Basic [1]   $ 2.07
Earnings Per Share, Diluted [1]   $ 2.07
[1] Restated per share amount reflects a reverse stock split of the outstanding shares of our Common Stock at a ratio of 1-for-8 effected on September 17, 2024.